SCHEMBL23050263

SCHEMBL23050263

CC(F)CCOC(=O)Nc1cc(Cl)nc(Cl)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.41
ACHE P22303 3/20 0.41
ATF1 P18846 1/20 0.40
NFKB1 P19838 1/20 0.40
ESR1 P03372 1/20 0.35
SMN1; SMN2 Q16637 7/20 0.34
HTT P42858 4/20 0.34
LMNA P02545 3/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
SLC13A3 Q8WWT9 1/20 0.34
HPGD P15428 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAPT P10636 3/20 0.34
TSHR P16473 2/20 0.34
MAPK1 P28482 2/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28066873 0.76 HPGD (0.48) ATF1NFKB1ESR1SMN1; SMN2HTT
SCHEMBL23050262 0.73 L3MBTL1 (0.39) BCHEACHESMN1; SMN2LMNANPC1
SCHEMBL23050297 0.73 L3MBTL1 (0.39) BCHEACHESMN1; SMN2LMNANPC1
SCHEMBL23050216 0.73 L3MBTL1 (0.35) BCHEACHESMN1; SMN2LMNANPC1
SCHEMBL1489997 0.70 ATF1 (0.48) ATF1NFKB1SMN1; SMN2LMNANPC1
SCHEMBL6508740 0.69 NPR3 (0.53) CYP2C9CYP2C19
SCHEMBL6508736 0.69 NPR3 (0.53) CYP2C9CYP2C19
SCHEMBL16372124 0.68 ATF1 (0.49) ATF1NFKB1SMN1; SMN2HTTLMNA
SCHEMBL10857111 0.67 KMT2A (0.49) BCHEACHESMN1; SMN2HTTNPC1
SCHEMBL5672221 0.66 MAPT (0.49) ESR1HTTLMNAMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3786166-A1 2-AMINOPYRIMIDINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF Etern Biopharma (Shanghai) Co., Ltd. (CN) 2021-03-03 EP disclosed